DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Janka-Schaub GE, Harms DO, den Boer ML, Veerman AJ, Pieters R.
In vitro drug resistance as independent prognostic factor in the study COALL-O5-92 Treatment of childhood acute lymphoblastic leukemia; two-tiered classification of treatments based on accepted risk criteria and drug sensitivity profiles in study COALL-06-97.
Klin Paediatr 1999; 211: 233-238
We do not assume any responsibility for the contents of the web pages of other providers.